Navigation Links
Pew and the Stewart Trust launch scholars program targeting cancer
Date:6/23/2014

PhiladelphiaThe Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the inaugural class of Pew-Stewart Scholars for Cancer Research. Five promising early-career scientists will receive funding for research aimed at finding cures for cancer using approaches that include genetics, pharmacology, and structural biology.

"Cancer continues to take a terrible toll on human health worldwide, and creative approaches are vital for the development of novel therapies," said Rebecca W. Rimel, Pew's president and CEO. "We are delighted to partner with the Stewart Trust to expand our commitment to science and eagerly anticipate the discoveries these talented researchers will make to address these challenges."

Pew has supported innovative research by young scientists through its biomedical scholars program http://www.pewtrusts.org/projects/pew-biomedical-scholars/ since 1985 and through the Pew Latin American fellows program http://www.pewtrusts.org/projects/pew-latin-american-fellows/ launched in 1991.

"Some of the most important health advances have stemmed from curiosity-driven investigations, and young researchers seem particularly primed to seed innovation in the field of cancer," said William Bierbower, executive trustee for the Stewart Trust, which for over 15 years has backed researchers probing the mechanisms of cancer.

"By combining forces with Pew, whose biomedical programs set the standard for selecting outstanding researchers, we believe we can leverage the most talented scientific minds to discover novel means of preventing, treating, and eventually curing cancer."

The Pew-Stewart scholars are assistant professor-level cancer researchers. They receive funding over four years and will have the opportunity to collaborate with Pew biomedical scholars and Latin American fellows at Pew's annual biomedical meeting.

Also announced today were the newest members of Pew's biomedical scholars and Latin American fellows programs, which support groundbreaking research by promising early-career biomedical researchers in the United States and Latin America.

The 2014 Pew-Stewart Scholars for Cancer Research are:

Arvin Dar, Ph.D.
Icahn School of Medicine at Mount Sinai
Oncology and chemical biology

Andrew Holland, Ph.D.
Johns Hopkins University School of Medicine
Cell biology and oncology

Shawn Douglas, Ph.D.
University of California, San Francisco
Pharmacology and nanotechnology

Agnel Sfeir, Ph.D.
New York University School of Medicine
Chromosome biology

Roberto Zoncu, Ph.D.
University of California, Berkeley
Cell biology and cancer metabolism

For the scholars' full abstracts and for more information about the program, please visit http://www.pewtrusts.org/projects/Pew-Stewart-Scholars-for-Cancer-Research/.


'/>"/>

Contact: Chelsea Toledo
ctoledo@pewtrusts.org
202-540-6846
Pew Health Group
Source:Eurekalert

Related biology news :

1. Entrust to Address Attendees, Exhibit at ICAO Eighth Symposium and Exhibition on MRTDs, Biometrics and Security Standards
2. Study details essential role of trust in agricultural biotech partnerships
3. $1 million Kenan Trust Grant extends support of Scripps Florida education outreach
4. Salk Institute awarded historic $42 million grant from the Helmsley Charitable Trust
5. Dont trust liposomes in your beauty products
6. CellTrust SecureSMS PULSE Integrated to Santech Health for Secure Text Messaging of Biometrics and PHI will be Demonstrated at HIMSS 2013
7. Many stressors associated with fracking due to perceived lack of trust, Pitt finds
8. Roy J. Carver Charitable Trust funds new research focus at Institute for Genomic Biology
9. Trust in leaders, sense of belonging stir people to safeguard common goods, analysis shows
10. Southerners are less trusting, but trust is a factor in environmental cooperation, study shows
11. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer ... hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. ... development activities. , “Dr. Floyd’s career has spanned 30 years in the chemicals ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... regeneration from small lab samples to full-size tissues, bones, even whole organs to ... vascular system that delivers blood deep into the developing tissue. , Current ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
Breaking Biology Technology: